178 related articles for article (PubMed ID: 36816355)
1. Comprehensive Analysis of Transcriptomic Profiles Identified the Prediction of Prognosis and Drug Sensitivity of Aminopeptidase-Like 1 (NPEPL1) for Clear Cell Renal Cell Carcinoma.
Wei X; Zhou Z; Ma G; Sun F
J Oncol; 2023; 2023():4732242. PubMed ID: 36816355
[TBL] [Abstract][Full Text] [Related]
2. Identification of potential biomarkers for progression and prognosis of renal clear cell carcinoma by comprehensive bioinformatics analysis.
Dong H; He Z; Wang H; Ding M; Huang Y; Li H; Shi H; Mao L; Hu C; Wang J
Technol Health Care; 2024; 32(2):897-914. PubMed ID: 37483037
[TBL] [Abstract][Full Text] [Related]
3. NUDT1 Could Be a Prognostic Biomarker and Correlated with Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Lin Y; Zhang F; Jin Y; Zhong Q; Tan W; Liu J; Wu Z
Appl Bionics Biomech; 2022; 2022():3669296. PubMed ID: 36606241
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma.
Zhang ZC; Liu YF; Xi P; Nie YC; Sun T; Gong BB
Hereditas; 2023 Jan; 160(1):1. PubMed ID: 36635779
[TBL] [Abstract][Full Text] [Related]
5. SLC22A8: An indicator for tumor immune microenvironment and prognosis of ccRCC from a comprehensive analysis of bioinformatics.
Xu K; Wu Y; Chi H; Li Y; She Y; Yin X; Liu X; He B; Li X; Du H
Medicine (Baltimore); 2022 Sep; 101(37):e30270. PubMed ID: 36123895
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of m
Wu J; Hou C; Wang Y; Wang Z; Li P; Wang Z
Int J Genomics; 2021; 2021():3803724. PubMed ID: 34631874
[TBL] [Abstract][Full Text] [Related]
7. Decreased Expression of ACADSB Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma.
Liu X; Zhang W; Wang H; Zhu L; Xu K
Front Oncol; 2021; 11():762629. PubMed ID: 35096573
[TBL] [Abstract][Full Text] [Related]
8. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
9. Integrated bioinformatics analysis to identify the key gene associated with metastatic clear cell renal cell carcinoma.
Miao S; Song J; Liu Q; Lai J; Wang H; Ran L
Med Oncol; 2022 Jun; 39(9):128. PubMed ID: 35716215
[TBL] [Abstract][Full Text] [Related]
10.
Wang B; Liu B; Luo Q; Sun D; Li H; Zhang J; Jin X; Cheng X; Niu J; Yuan Q; Chen Y
Transl Cancer Res; 2022 Jul; 11(7):2321-2337. PubMed ID: 35966310
[TBL] [Abstract][Full Text] [Related]
11. Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis.
Sui Y; Lu K; Fu L
PeerJ; 2021; 9():e11272. PubMed ID: 33976979
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive analysis of the prognostic value and immune infiltration of low expression DBT in clear cell renal cell carcinoma.
Xie W; Xi P; Liu Y; Zhang Z; Sun T
Front Pharmacol; 2022; 13():1002588. PubMed ID: 36299888
[No Abstract] [Full Text] [Related]
13. Caspase 4 Overexpression as a Prognostic Marker in Clear Cell Renal Cell Carcinoma: A Study Based on the Cancer Genome Atlas Data Mining.
Meng L; Tian Z; Long X; Diao T; Hu M; Wang M; Zhang W; Zhang Y; Wang J; He Y
Front Genet; 2020; 11():600248. PubMed ID: 33584797
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of an integrative methylation signature and nomogram for predicting survival in clear cell renal cell carcinoma.
Peng Q; Zhou Y; Jin L; Cao C; Gao C; Zhou J; Yang D; Zhu J
Transl Androl Urol; 2020 Jun; 9(3):1082-1098. PubMed ID: 32676392
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of IRF3 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma.
Wu J; Leng X; Pan Z; Xu L; Zhang H
Int J Gen Med; 2021; 14():5675-5692. PubMed ID: 34557022
[TBL] [Abstract][Full Text] [Related]
16. A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma.
Chen Z; Liu X; Zhu Z; Chen J; Wang C; Chen X; Zhu S; Zhang A
Front Genet; 2022; 13():1039465. PubMed ID: 36338978
[No Abstract] [Full Text] [Related]
17. Comprehensive analysis of the expression, prognostic value and biological importance of OVO‑like proteins in clear cell renal cell carcinoma.
Lin J; Jiang M; Chen R; Zheng P; Chen G
Oncol Lett; 2023 May; 25(5):179. PubMed ID: 37033105
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil extracellular traps-associated modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of clear cell renal cell carcinoma.
Teng ZH; Li WC; Li ZC; Wang YX; Han ZW; Zhang YP
Front Oncol; 2022; 12():1094248. PubMed ID: 36620592
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma.
Zhang H; Liu Y; Wang B; Wang C
BMC Genom Data; 2022 Jul; 23(1):58. PubMed ID: 35883015
[TBL] [Abstract][Full Text] [Related]
20. A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.
Gao J; Ye F; Han F; Jiang H; Zhang J
Front Immunol; 2022; 13():956679. PubMed ID: 36177018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
